Catalyst Wire Dossier Catalyst Wire Dossier

CD19/BCMA CAR T-cells

· Institute of Hematology & Blood Diseases Hospital, China
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19/BCMA CAR T-cells, covering 2024-12-13 to 2024-12-13. Get the full timeline:

Most recent: Clinical Trial Update: CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy. [Phase 1]

See pricing